News

Starting in early 2021, Apple (NASDAQ: AAPL) will begin prompting users to opt in or out of application activity tracking. Alphabet's (NASDAQ: GOOGL)(NASDAQ: GOOG) Google is expected to eventually

It's easy to miss the big picture with stocks by following headlines. Writers focus on whatever fascinates investors at the moment, and why shouldn't they? It's what people most want to read about.

The pandemic is going to end. No more shutdowns. No more social distancing. And no more masks.

What remains unknown, though, is how long it's going to take. The first shipments of COVID-19 vaccines

Great dividend stocks can be the gems in a portfolio and provide cash flow for decades of an investor's life. But finding dividend stocks that are built to last may not be as easy as it seems

There are some areas of the stock market that obviously stand to benefit as the COVID-19 pandemic begins to wind down in 2021. For example, we all know that cruise lines, airlines, and hotel

The U.S. Food and Drug Administration (FDA) granted Pfizer's (NYSE: PFE) coronavirus vaccine candidate Emergency Use Authorization (EUA) last week. On Dec. 17, the FDA will meet with its vaccine

Investing in 2020 has not been without its challenges. The unprecedented coronavirus disease 2019 (COVID-19) pandemic led to historic levels of uncertainty in the market. During the first quarter

It might seem like everything is going well for COVID-19 vaccines right now. The first Americans have already been vaccinated with Pfizer's (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) BNT162b2

There's no denying that the trend toward e-commerce had already gained a significant foothold before the pandemic struck. There's also overwhelming evidence that that trend took a giant step forward

Most investors buy shares of great companies looking for growth in the share price. Some are looking more for a consistent source of passive income in the form of dividends. And then there are

Image source: Getty Images.

While it doesn't influence our opinions of products, we do receive compensation from partners whose offers appear here. We're on your side, always. See our full

When little under-the-radar companies are compared to mega-corporations, it's often little more than unfounded hype. That's how I felt when I first started hearing Jumia Technologies (NYSE: JMIA)

On Dec. 17, the Food and Drug Administration will consider Moderna's (NASDAQ: MRNA) request for Emergency Use Authorization for its coronavirus vaccine. The biotech company also has approached

It's been an incredibly wild year on Wall Street. Yet when investors cross the finish line for 2020 in less than two weeks, they'll potentially be looking at double-digit gains.

Although the

Investors saw a little bit of everything in 2020. The stock market started the year by rising to new highs, only to suffer a lightning-fast bear market plunge that lopped 30% off major market

Image source: The Motley Fool.

American Outdoor Brands Inc (NASDAQ: AOUT)Q2 2021 Earnings CallDec 15, 2020, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

We'll see many more of Apple's (NASDAQ: AAPL) iPhones next year, since the company apparently plans to ramp up their production. 

On Tuesday, Nikkei Asia reported that the powerful tech company aims

Two notable names in the cannabis industry might be combining their businesses. According to a report published after market hours Tuesday by Bloomberg that cited "sources familiar with the matter,"

IBM (NYSE: IBM) announced today that it has bought Expertus Technologies, a Montreal-based fintech. Expertus offers a payments-as-a-service solution that will enhance payments options in IBM's

There was good news with Moderna (NASDAQ: MRNA) on Tuesday regarding its closely followed mRNA-1273 coronavirus vaccine candidate. However, comments made by a health expert who has the ear of the

Marijuana stocks closed Tuesday trading broadly higher -- and the smaller they were, the higher they popped.

Tiny HEXO (NYSE: HEXO) closed the day up 7.9%, while Aurora Cannabis (NYSE: ACB) rose

Shares of Anavex Life Sciences (NASDAQ: AVXL) -- a clinical-stage biopharmaceutical company -- rose by as much as 22.9% on Tuesday and closed the day's trading session up by 15.4%. Investors reacted

Investors got a nice rally on Wall Street on Tuesday, as enthusiasm about the prospects for a full economic recovery in 2021 has taken hold of market participants. Gains were broad-based, with the

Never shy to open its wallet for an asset buy, Goldman Sachs (NYSE: GS) is reaching across our northern border for its latest acquisition. On Monday, Canada-based benefits manager and human

Shares of solar stocks jumped across the board today on positive rumors from Washington, D.C. Shares of solar energy stocks have run up ahead of the election of President-elect Joe Biden, and we may